Ticasave Plus Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticasave Plus Tablet
CardioGuard Plus tablets are classified as antiplatelet agents, effectively reducing the risk of harmful blood clot formation within blood vessels. This preventative action lowers the likelihood of heart attacks and strokes in patients with pre-existing heart conditions. CardioGuard Plus is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (chest pain), or who have received cardiac stenting. It helps prevent future cardiac events, including recurrent heart attacks, strokes, and stent thrombosis. Concurrent use with aspirin, another antiplatelet medication, will typically be prescribed by your physician. CardioGuard Plus can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during symptom-free periods, as discontinuation elevates the risk of cardiovascular events. The most frequently reported adverse effect is increased bleeding tendency; injuries may bleed more profusely and for longer than usual. While typically mild and self-limiting, prolonged or excessive bleeding should be reported. Some patients may experience mild shortness of breath, which usually subsides with continued therapy. Report persistent or worsening breathlessness to your physician. CardioGuard Plus is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to initiating treatment.
Uses of Ticasave Plus Tablet
Averting cardiovascular events such as myocardial infarction and cerebrovascular accident
Major Benefits of Ticasave Plus Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticasave Plus Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Ticasave Plus Tablet:
- Bleeding
- Breathlessness
How to use Ticasave Plus Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or fracture it. Ticasave Plus Tablets can be administered with or without food, although consistent timing is recommended.
How Ticasave Plus Tablet works:
Ticasave Plus tablets offer antiplatelet action, inhibiting platelet aggregation to reduce the risk of dangerous blood clot development, thus lessening the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Ticasave Plus Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Use of Ticasave Plus Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticasave Plus Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticasave Plus Tablet.
KidneySAFE IF PRESCRIBED
Ticasave Plus Tablets are considered safe for individuals with kidney impairment; no dosage alteration is advised. Data regarding Ticasave Plus Tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticasave Plus Tablet cautiously, potentially requiring dosage modification under medical supervision. Ticasave Plus Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ticasave Plus Tablet :
Should you forget a Ticasave Plus Tablet dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ticasave Plus Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |




